PSO(PSO)
PSO
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E | FY2029E |
|---|---|---|---|---|
| Revenue Avg | $3.72B | $3.89B | $4.06B | $3.58B |
| Low | $3.70B | $3.86B | $4.02B | $3.54B |
| High | $3.76B | $3.94B | $4.11B | $3.62B |
| EBITDA Avg | $1.12B | $1.11B | $1.12B | $1.15B |
| Low | $1.03B | $1.01B | $1.11B | $1.14B |
| High | $1.16B | $1.17B | $1.13B | $1.16B |
| EBIT Avg | $641M | $706M | $776M | $850M |
| Low | $549M | $601M | $765M | $838M |
| High | $684M | $767M | $786M | $862M |
| Net Income Avg | $469M | $522M | $579M | $640M |
| Low | $393M | $436M | $570M | $631M |
| High | $504M | $572M | $588M | $650M |
| EPS Avg | $0.71 | $0.79 | $0.88 | $0.97 |
| Low | $0.60 | $0.66 | $0.86 | $0.95 |
| High | $0.76 | $0.87 | $0.89 | $0.98 |
| Analysts (Rev / EPS) | 7 / 3 | 7 / 3 | 3 / 1 | 3 / 1 |